Bayer Corporation
Related Organizations
Data about an organization is collected from a variety of government sources and there is no standardized name or common identifier across data sources. Digital Democracy experts make judgments about which entries are related, such as an organization that has various spellings or a corporation and its affiliates. Those relationships are used to determine financial contributions and advocacy on legislation. Below are the entities that Digital Democracy has linked to the organization above:
- Bayer Healthcare
- Bayer
- Bayer Health Care
- Bayer US LLC
- Bayer U.S. LLC
- Bayer Healthcare LLC
- BAYER US
- Bayer US, LLC
Lobbying Representations
This list shows when this lobbyist testified in a hearing, who they were representing and which bill was involved. The data covers 2015-18 and 2023-present.
Date | Lobbyist | Bill | Hearing | Testimony |
|---|---|---|---|---|
| July 16, 2025 | Nico Molina | AB 432 | Health | Testimony Link |
| July 7, 2025 | Nico Molina | AB 432 | Business, Professions and Economic Development | Testimony Link |
| April 29, 2025 | Nico Molina | AB 432 | Health | Testimony Link |
| April 22, 2025 | Nico Molina | AB 432 | Business and Professions | Testimony Link |
| April 8, 2025 | Nico Molina | AB 360 | Business and Professions | Testimony Link |
| April 23, 2024 | Craig Swaim | AB 2467 | Health | Testimony Link |
Bill Alignment
Bill Alignments represents this person's position on legislation and, where it applies, the organization they were representing. These positions are captured from in-person testimony and written positions that have been submitted to committees. The data covers 2015-18 and 2023-present.
Year:
Bill | Representing | Last Recorded Position | |
|---|---|---|---|
| AB 432: Menopause. | Self | Support | |
| AB 360: Menopause. | Self | Support |
Financials
Below is a list of financial exchanges between this organization and legislators including campaign donations, gifts, independent expenditures or travel expenses. The data covers 2015-present.
Financials Loading...
